Back to Results
First PageMeta Content
Vaccine / Cell culture / Vaccination / Virus / Biology / Biotechnology / Ventria Bioscience


Document Date: 2012-07-19 17:43:19

Open Document

File Size: 101,19 KB

Share Result on Facebook

City

Ann Arbor / /

Company

InVitria / Ventria Bioscience / SoloHill Engineering Inc. / /

Country

United States / /

Currency

USD / /

/

Facility

The Institute / Utah State University / National Institute of Allergy / Fort Collins / /

/

IndustryTerm

cell‐based biomanufacturing systems / cell culture media / end product / industry‐standard media / defined media / cost‐effective biologic products / inconsistent manufacturing / egg‐based manufacturing / /

MedicalCondition

nearly eradicated smallpox / childhood vaccine‐preventable diseases / paralytic polio / infectious agents / /

MedicalTreatment

mass vaccination / /

Organization

Division of Ventria Bioscience / U.S. Centers for Disease Control and Prevention’s Division of Vector‐Borne Diseases / National Institute of Allergy / Utah State University / Institute for Antiviral Research / /

Person

Steven Pettit / Scott Deeter / Michael F. Bennet / Erik Vogel / /

/

Position

director of cell culture development and the principal investigator / president and CEO / /

Product

InVitria Division Awarded 2 / /

ProvinceOrState

Utah / Colorado / Michigan / /

PublishedMedium

Antiviral Research / /

Technology

prions / biomanufacturing / biomanufacturing technology / /

URL

www.ventria / www.ventria.com / /

SocialTag